Company / Depreciation & Amortization
Q32 Bio Inc. Depreciation & Amortization History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$487.0K
FY2025
5-year range
$487.0K / $8.4M
FY2021-FY2025
Trend
-2.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has declined for 3 consecutive years, from $8M in FY2022 to $487,000 in FY2025.
Based on SEC 10-K filings.
$487,000 in FY2025 with a 5-year CAGR of -40.1%.
Improved from $1M to $487,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -61.2%
- 5-Year CAGR
- -40.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Q32 Bio Inc.'s depreciation & amortization has declined for 3 consecutive years.
- 5-year CAGR of -40.1%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 2.4% year-over-year.
- Peak depreciation & amortization was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $487.0K | -2.4% |
| FY2024 | $499.0K | -61.4% |
| FY2023 | $1.3M | -84.5% |
| FY2022 | $8.4M | +4.9% |
| FY2021 | $8.0M | +26.1% |
| FY2020 | $6.3M | +390.1% |
| FY2019 | $1.3M | +88.5% |
| FY2018 | $684.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026